Skip to content

Daily protein synthesis rates in all human tissues

Daily protein synthesis rates in all human tissues - Daily protein synthesis rates in all human tissues

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58539
Enrollment
40
Registered
2025-12-22
Start date
2026-02-02
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

protein metabolism protein metabolism

Interventions

All subjects will undergo a standardized deuterated water dosing protocol for three days prior to their elective surgery.

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria adults= 18 years oldPlanned surgery that includes the (partial) resection of organ tissue(s)18.5 = BMI = 35 kg/m2Written informed consent Inclusion criteria children= 8 years old and = 14 years oldPlanned surgery that includes the (partial) resection of organ tissue(s)14 = BMI = 35 kg/m2Written informed consent by parents (and child, in case of age 12-14 years old)

Exclusion criteria

Exclusion criteria: Recent (<6 months) participation in 2H2O tracer studiesCachexia (loss of 5% or more of body weight over the preceding 6 months)Score of 2 or more on the Malnutrition Universal Screening Tool (MUST) for adults or score of 1 on subitem 2, 3 and/or 4 of the STRONGkids Screening Tool for childrenInsulin dependent diabetes mellitusCo-morbidities and neuromuscular disorders of the lower limbs severely interacting with mobility with limited or no opportunity for improvement (e.g. cerebral palsy)Peripheral arterial disease Fontaine III or IVChronic obstructive pulmonary disease (COPD) GOLD III or IVUse of systemic steroids in the past four weeks, other than indicated for the specific type of surgeryUse anti-inflammatory biologicals (e.g. TNF-alfa blockers) in the past four weeksNeoadjuvant chemo- or radiotherapy in the past four weeksSurgical intervention in the past four weeksPregnancyAny other medication or (medical) condition that may interfere with the safety of the subjects or the outcome parameters, in the investigators judgementInvestigator’s uncertainty about the willingness or ability of the subject to comply with the protocol instructions

Design outcomes

Primary

MeasureTime frame
Primary study parameters include daily protein synthesis rates and enrichments in a variety of organ tissues throughout the human body, including brain, heart, lung, liver, intestinal, hepatic and musculoskeletal tissues. 

Secondary

MeasureTime frame
Niet van toepassing.

Countries

Netherlands

Contacts

Public ContactL.J.C. van Loon

Universiteit Maastricht

secretariaat-nutrim@maastrichtuniversity.nl+31433881476

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026